1. Introduction {#sec1-ijerph-17-03001}
===============

The translational applications of regenerative medicine may impact on several fields of medicine. In the past ten years, the relatively new field of regenerative dentistry has achieved several discoveries, such as biomimetic materials, new orally derived stem cells, or interesting methods to populate scaffolds with cells and bioactive factors \[[@B1-ijerph-17-03001],[@B2-ijerph-17-03001],[@B3-ijerph-17-03001],[@B4-ijerph-17-03001],[@B5-ijerph-17-03001],[@B6-ijerph-17-03001],[@B7-ijerph-17-03001],[@B8-ijerph-17-03001]\]. Typically, biomaterials can be synthetic or derived from several homologous and heterologous biological tissues. Mesenchymal stem cells (MSCs) are the main players of tissue regeneration; in the case of large bone defects, MSCs can be combined with scaffolds, achieving reparative or reconstructive results that are more effective than the physiological healing process \[[@B9-ijerph-17-03001],[@B10-ijerph-17-03001]\].

Regenerative medicine procedures consist of surgical protocols that improve both the healing time and quality. The use of bioscaffolds in a surgical site can drive local stem cells towards the site in order to regenerate the surrounding tissue, while also enabling improved differentiation between specific phenotypes \[[@B11-ijerph-17-03001],[@B12-ijerph-17-03001],[@B13-ijerph-17-03001]\].

Several clinical applications of tissue engineering are well reported in the scientific literature. Studies on bone regeneration have combined mesenchymal stem cells derived from bone marrow and bioscaffolds, comparing such constructs with titanium mesh alone in the treatment of defects affecting the mandibular bone \[[@B13-ijerph-17-03001]\]. Furthermore, the use of adipose stem cells (ASCs) as scaffolds in micro-vascularized flaps has shown promising results in the treatment of bone defects \[[@B14-ijerph-17-03001]\].

A revolution is underway in the field of new materials; in fact, biomaterials have always been used to perform specific anatomical functions; however, today, the trend is to integrate their function within the material itself, thus developing scaffolds made up of multifunctional materials that can 'feel the surrounding tissue' and 'react to it' \[[@B11-ijerph-17-03001],[@B12-ijerph-17-03001]\]. In the past, inert materials were used to rebuild or replace an organ; these were mostly metals, such as surgical steel. Over time, they have been overcome by materials that have mechanical, chemical and structural properties that can interact with the human body and surrounding tissues. Recently, biomaterial has also undergone development in manufacturing, with the introduction of technologies such as rapid prototyping or 3D printing, which have enabled the engineering and customization of grafting materials \[[@B13-ijerph-17-03001],[@B14-ijerph-17-03001],[@B15-ijerph-17-03001]\].

The recent literature has, therefore, confirmed that the combination of MSCs, biomaterials and local growth factors can undoubtedly support the regeneration/repair of three-dimensional structures in different anatomic areas \[[@B15-ijerph-17-03001],[@B16-ijerph-17-03001]\]. ([Figure 1](#ijerph-17-03001-f001){ref-type="fig"}).

Recently, a novel intriguing approach was hypothesized: scaffold-free tissue engineering. We aim to briefly and critically discuss the most reliable, promising and predictable techniques of scaffold-free tissue regeneration and compare them to traditional techniques.

2. Searching Strategy {#sec2-ijerph-17-03001}
=====================

The first articles reporting the term "scaffold" in the scientific literature were published in the early 1960s. Then, the primary interest in scaffold applications was in relation to bone reconstruction. However, the term scaffold underwent several changes in the period between 1960 and 1980. In our narrative critical review, we have analysed the impact of the keyword "scaffold" in the title, in the abstract, and in the main text of articles published in PubMED-indexed journals in the timespan ranging from 1980 to 2020. Dental tissue engineering has pointed out a number of useful and smart alternatives to the classic concept of a scaffold; we considered the combination of terms such as "Platelets concentrates", "Extracellular Matrix", "Stem Cells", "Proteins" and "Exosomes". The main task in this preliminary step was to evaluate whether the topic discussed in these articles was relevant or not to our main aim, and to critically discuss such items alone and in comparison with each other.

When searching for the above-reported keywords in PubMed, we found 2215 items reported. Only highly impacted or well-recognized journals were considered in our research, as they represent a reliable and balanced selection of the most influential authors. Case reports, editorials, letters to editors, technical notes and brief reviews were not included in our overview.

The authors screened the title and abstract of the first selected articles and, after the exclusion of articles based on misleading topics, 173 papers related to the topic were considered and included in our overview.

First, we established the main objective of the work and the field (dentistry) considered in our study. In the second stage, we critically selected, read and compared the most interesting articles. Based on the expertise of the authors, we decided to select only the most relevant outcomes.

After the removal of duplicate articles, and other publication types, such as erratum and corrigendum, a total of 12 articles were selected for this review.

The main limitations of this study relate to the wide topic and the scarce observation time of the scaffold-free approaches, in comparison with the more predictable scaffolds, which have been well described and documented over the past forty years. Finally, the critical approach reported in this review is based on the authors' expertise and insights into the matter, as the topics are substantially incomparable.

3. Scaffold-Free Approaches {#sec3-ijerph-17-03001}
===========================

3.1. Exosomes in Regenerative Dentistry {#sec3dot1-ijerph-17-03001}
---------------------------------------

The scientific evidence shows the strong immunomodulatory activity of mesenchymal stem cells. MSCs conduct paracrine secretory activities, which allow MSCs to induce pleiotropic effects, especially local immunomodulation \[[@B17-ijerph-17-03001]\]. In 1967, Wolf and colleagues characterized various types of extracellular vesicles (EVs): such vesicles were originally named "platelet dust" \[[@B18-ijerph-17-03001]\]. EVs are released into the local environment and are created from the membrane of the vast majority of cells. In fact, they are delimited by a phospholipidic bilayer, similar to the cell from which they have been generated. These small vesicles are able to carry cell-specific loads, typically affecting the activity of target cells. A number of crucial cell processes, including cell-to-cell communication and the modulation of immune responses, are based on EV activity. The diameter of EVs is relevant for their characterization and they are divided into the following categories: (a) apoptotic bodies (\>1000 nm), (b) microvesicles (100--1000 nm) and (c) exosomes (30--150 nm) \[[@B19-ijerph-17-03001]\]. It is commonly accepted that MSC-derived exosomes are one of the key paracrine effectors, through which MSCs can modulate tissue repair. The therapeutic effect of MSC-based therapy is largely caused by the local release of exosomes, which deliver specific molecules (proteins, nucleic acids, and lipids) to the local cells and tissues. Several intracellular proteins, such as mRNA, miRNA, and lipids, are carried by exosomes \[[@B20-ijerph-17-03001]\]. These components can regulate tissue formation by inhibiting or promoting specific pathways, according to the variable biology of the target site. In this landscape, exosome-based therapy can be applied to treat several disorders. For example, Joo et al. have shown the therapeutic effects of exosomes in heart, kidney, lung, skin, muscle, and brain diseases \[[@B21-ijerph-17-03001]\].

In the field of dental medicine, bone tissue regeneration is a fundamental process involved in the majority of therapies \[[@B14-ijerph-17-03001]\]. Angiogenesis plays a significant role in bone tissue repair, contributing to both bone growth and bone graft survival. Exosomes have been reported to induce local angiogenesis in bone regeneration: specifically, oral-derived stem cells are able to secrete exosomes loaded with pro-angiogenic miRNAs and direct them towards the local endothelial cells. Moreover, these small vesicles carry several biomolecules that possess signaling functions \[[@B18-ijerph-17-03001],[@B19-ijerph-17-03001]\]. Petho et al. demonstrated that specific molecules carried by MSC-derived exosomes spread biochemical signals, promoting osteoblast differentiation and downregulating osteoclast formation \[[@B22-ijerph-17-03001]\].

Exosomes can be used as biomimetic tools, as they are able to trigger stem cell differentiation. Chun-Chieh et al. \[[@B23-ijerph-17-03001]\] highlighted how dental pulp stem cell (DPSC)-derived exosomes induce odontogenic differentiation in human dental pulp stem cells (DPSCs). Exosomes work by triggering strategic changes in MSCs, increasing odontogenic-related gene expression in vitro. Chew et al. investigated a ready-to-use and cell-free strategy for the treatment of periodontal defects in an immunocompetent rat model \[[@B24-ijerph-17-03001]\]. They used human MSC-derived exosomes and investigated their therapeutic effects on the healing process. The findings of this study suggest that exosome-based therapy can be applied to promote bone formation and periodontal regeneration. Based on such exciting results, the translational use---in several dental applications---of these nano-sized vesicles can be considered promising and worthy of being investigated further and in more depth by dentists in the coming years.

3.2. The Hypoxia-Based Approach in Regenerative Dentistry {#sec3dot2-ijerph-17-03001}
---------------------------------------------------------

Recent studies have highlighted the possibility of empowering the immunosuppressive, immunomodulatory and regenerative potential of stem cells through pre-conditioning techniques that work by using cytokines, hypoxia and other molecules \[[@B25-ijerph-17-03001]\]. Interestingly, the hypoxia-based approach has been investigated in several studies aimed to compare exosomes obtained from hypoxia-subjected MSCs, and exosomes obtained from normally cultured MSCs; the results show that the experimental protocol promoted angiogenesis in a significant way \[[@B26-ijerph-17-03001],[@B27-ijerph-17-03001],[@B28-ijerph-17-03001]\]. Moreover, microvesicles derived from hypoxia-subjected MSCs can influence the immune response, \[[@B29-ijerph-17-03001],[@B30-ijerph-17-03001],[@B31-ijerph-17-03001]\]. These immunomodulatory microparticles are able to both reduce local inflammation and support cell proliferation and migration. Regenerative dentistry may be supported by hypoxia-based MSC exosomes in the local induction of neo-angiogenesis \[[@B32-ijerph-17-03001],[@B33-ijerph-17-03001]\]. In fact, newly formed tissues require strong vascularization to ensure the presence of nutrients and growth factors and to support cell vitality, proliferation and differentiation. In a recent review, Zimta et al. \[[@B34-ijerph-17-03001]\] summarized the available techniques to maximize the pro-angiogenic procedures applied in regenerative dentistry. In this review, the authors have focused on such micro-RNAs (miRNAs) that are able to influence the behavior of endothelial cells: these molecules will be used as pro-angiogenic factors in oral wound repair and regeneration \[[@B35-ijerph-17-03001]\]. Hypoxia-induced exosomes can be considered pro-angiogenic factors; essentially, these exosomes can stimulate the miR-135b target and hypoxia-inducible factor 1 (HIF-1). This peculiarity enhances angiogenesis, by positively regulating the expression of pro-angiogenic mediators acting in the oral tissues \[[@B35-ijerph-17-03001],[@B36-ijerph-17-03001]\]. In conclusion, the biological condition of hypoxia appears to be strategic external stress, which is able to enhance the pro-angiogenic activity of conditioned MSCs by releasing bioactive exosomes.

3.3. Heat Shock Proteins (HSPs) in Regenerative Dentistry {#sec3dot3-ijerph-17-03001}
---------------------------------------------------------

Periodontal pathologies are one of the most common chronic inflammatory diseases affecting the oral cavity \[[@B37-ijerph-17-03001]\]. They are classified into different diagnostic categories \[[@B38-ijerph-17-03001]\], chronic periodontitis (CP) and acute periodontitis (AgP) \[[@B39-ijerph-17-03001]\]. In recent decades, many diagnostic and prognostic biomarkers have been proposed to treat periodontitis. Heat shock proteins (HSPs) seem to work well in promoting tissue regeneration \[[@B40-ijerph-17-03001]\] and are normally produced by cells exposed to stressful conditions. In 2010, Henderson et al. measured plasma levels of HSP10 and HSP60 in subjects with chronic periodontitis, and healthy subjects \[[@B41-ijerph-17-03001]\]. In this study, patients with chronic periodontitis showed significantly lower levels of HSP10, compared with healthy subjects; on the other hand, no significant difference was found in HSP60 levels. After a full periodontal treatment, the experimental group reported a significant increase in HSP10 levels, demonstrating the prognostic role of some circulating stress-related proteins as reliable indicators of successful periodontal treatments.

Heat shock protein 27 (HSP27), compared to HSP60, was investigated with the aim of understanding more about its ability to modulate intracellular responses to specific inflammatory signals by promoting anti-inflammatory pathways \[[@B42-ijerph-17-03001],[@B43-ijerph-17-03001]\]. Blood levels of HSP27 seem to be related to different types of periodontitis, as assessed by Kaiser et al. \[[@B44-ijerph-17-03001]\]. The researchers found lower levels of HSP27 in a test group of patients suffering from aggressive periodontitis, compared to a second group involving patients suffering from chronic periodontitis and a third group involving only healthy subjects \[[@B45-ijerph-17-03001],[@B46-ijerph-17-03001]\]. Furthermore, no differences were found in terms of HSP60 levels between the three groups described above. On the other hand, the study demonstrated a specific correlation between the levels of HSP27 in subjects with chronic periodontitis and healthy subjects. This evidence means that HSPs may play different roles in the modulation of different types of periodontitis. Specifically, HSP27 seems to be useful and appears to be involved in the regulation of the healing of acute periodontitis, as it increases in healthy subjects and in those subjects that have overcome the acute stage of periodontitis.

4. Conclusions and Future Insights {#sec4-ijerph-17-03001}
==================================

In our critical overview, we have pointed out the main pros and cons of both the approaches, with the most recent and promising literature sources ([Table 1](#ijerph-17-03001-t001){ref-type="table"}).

The micro- and nano-vesicles, such as the exosomes, have widely been demonstrated to be an effective approach, including through the use of the conditioned medium as a substitute for stem cells in the biological niche. Heat shock proteins (HSPs) and hypoxia-primed MSCs are also interesting, even if the subsequent continuous and uncontrolled/inhomogeneous stress to cell biology may trigger atypical replies from stem cells, producing anomalous clones and potential anomalous behavior by the regenerative niche.

Nowadays, no meaningful protocol for the in vivo application of a scaffold-free approach in translational dentistry exists. Future approaches may, of course, provide the proper combination of all the techniques reported here, and the authors cannot exclude the hypothesis that novel and smarter biomaterials may revolutionize the market of tissue engineering. As a matter of fact, the best approach does not exist at all: the only way to proceed is to analyze the clinical case closely and to use the best technique on a case-by-case basis. Generally and typically, large defects requiring wide replacements should always be performed with a scaffold-based approach; on the contrary, small lesions that are likely to be self-repairing may be treated with scaffold-free approaches to speed-up and improve the healing process.
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###### 

Comparative table reporting the main scaffold-based and scaffold-free approaches in regenerative dentistry.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study Model                                       Type of Disease                   Therapeutic Approaches                       Main Results                                                                                References
  ------------------------------------------------- --------------------------------- -------------------------------------------- ------------------------------------------------------------------------------------------- ---------------------------------------------------
  Fibrin sealant                                    Extraction wounds                 Human plasma derivatives\                    Fibrin sealants enhance the healing process                                                 Moller et al. 1988 \[[@B1-ijerph-17-03001]\]
                                                                                      (Cell/scaffold-free)                                                                                                                     

  Platelet-rich plasma (PRP)                        Postoperative injury sites        Human plasma derivatives\                    The PRP delivers growth factors at the treated site                                         Whitman et al. 1997 \[[@B2-ijerph-17-03001]\]
                                                                                      (Cell/scaffold-free)                                                                                                                     

  Platelet-rich plasma (PRP)                        Maxillary sinus-lift              Human plasma derivatives\                    Improvement in implant-prosthetic rehabilitation                                            Inchingolo et al. 2012 \[[@B3-ijerph-17-03001]\]
                                                                                      (Cell/scaffold-free)                                                                                                                     

  Platelet-rich fibrin (PRF)                        Posto-operative surgical sites    Human plasma derivatives\                    PRF appears to accelerate the physiologic healing process                                   Dohan et al. 2006 \[[@B6-ijerph-17-03001]\]
                                                                                      (Cell/scaffold-free)                                                                                                                     

  Platelet-rich fibrin (PRF)                        Post-extractive dental implants   Human plasma derivatives\                    Improving the bone quality and the healing of soft tissues                                  Marrelli et al. 2013 \[[@B7-ijerph-17-03001]\]
                                                                                      (Cell/scaffold-free)                                                                                                                     

  DPSCs + hydrogel scaffolds (bECM) + GFs           In vitro experiments              Cell/scaffold/GFs                            Up-regulation of osteogenic genes                                                           Paduano et al. 2016 \[[@B9-ijerph-17-03001]\]

  Cell sheets engineering (CSE)                     In vitro experiments              Scaffold-free cell sheet engineering (CSE)   Improving of cell growth to improve the viability of the cell grafts                        Moschouris et al. 2016 \[[@B12-ijerph-17-03001]\]

  The microvascular custom-made ectopic bone flap   Hemi-maxillectomy                 Cell/scaffold/GFs                            Reconstruction of large defects                                                             Mesimaki et al. 2009 \[[@B14-ijerph-17-03001]\]

  DPSCs + Exosomes                                  In vitro experiments              Cell/biomolecules                            Culture and growth of dental pulp-like tissue in a tooth-root model                         Chun-Chieh et al. 2016 \[[@B23-ijerph-17-03001]\]

  MSC-derived exosome-loaded collagen sponge        Periodontal defects               Cell/scaffold/biomolecules                   Periodontal tissue regeneration through increased cellular mobilization and proliferation   Chew et al. 2019 \[[@B24-ijerph-17-03001]\]

  Exosomes from hypoxia-cultured MSCs               In vitro experiments              Cell/biomolecules                            Anti-inflammatory activity                                                                  Showalter et al. 2019 \[[@B31-ijerph-17-03001]\]

  Exosomes-derived miRNA                            In vitro experiments              Cell/biomolecules                            Pro-angiogenic activity                                                                     Zimta et al. 2019 \[[@B34-ijerph-17-03001]\]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[^1]: They are co-last authors.
